|
We process and analyze primary and secondary data for research purposes. We have analyzed data and co-authored papers deriving from health-insurance claims,
clinical trials, and government surveys.
Our specific analytical expertise includes:
- Pharmacoeconomic analyses associated with Phase III & Phase IV trials;
- Cost of Illness analyses associated with musculoskeletal and pulmonary chronic diseases; and
- Development and evaluation of risk adjustment/risk assessment techniques associated with medical reimbursement.
Our multiple years of experience managing data provided in various media from different platforms
allow us to quickly ascertain the most efficient way to import and reshape data for analysis. In addition, we distinguish
ourselves by taking the time to understand your research question as our first step, thereby avoiding unnecessary efforts
and analytical dead ends.
|
